[Clinical features and prognosis in juvenile myasthenia gravis].
D000293:Adolescent; D002648:Child; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005132:Eye Manifestations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis
D002800:Cholinesterase Inhibitors